Evoke plc (LON:EVOK – Get Free Report) traded up 14.5% on Thursday . The stock traded as high as GBX 48.90 ($0.64) and last traded at GBX 48.90 ($0.64). 42,064,105 shares traded hands during trading, an increase of 1,236% from the average session volume of 3,148,381 shares. The stock had previously closed at GBX 42.70 ($0.56).
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group reiterated a “buy” rating and issued a GBX 140 ($1.83) price target on shares of Evoke in a research report on Monday, December 16th.
Get Our Latest Report on Evoke
Evoke Stock Down 4.9 %
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, sell-side analysts predict that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Transactions at Evoke
In other news, insider Andrea Gisle Joosen purchased 14,572 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 70 ($0.92) per share, with a total value of £10,200.40 ($13,351.31). Also, insider Jonathan (Jon) Mendelsohn purchased 200,000 shares of the stock in a transaction on Monday, March 31st. The stock was acquired at an average cost of GBX 48 ($0.63) per share, with a total value of £96,000 ($125,654.45). Company insiders own 27.00% of the company’s stock.
About Evoke
Featured Stories
- Five stocks we like better than Evoke
- Differences Between Momentum Investing and Long Term Investing
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- Why Invest in High-Yield Dividend Stocks?
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- What is a SEC Filing?
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.